Mesoblast gets boost from positive FDA news in USA
MELBOURNE: Shares in Australian biopharmaceutical company Mesoblast jumped as much as 25 per cent after
MELBOURNE: Shares in Australian biopharmaceutical company Mesoblast jumped as much as 25 per cent after
FEATURED
Global pilot shortage could mean push to raise retirement age
Dementia now the leading cause of death in the elderly
Chemist captured 42% of market for aged care
Trend for retirees to return to work is growing
Hop, skip and jump for strength and bone density says adherent
New affordable housing complex opens for seniors on fixed incomes
INNOVATION
